The Personal Education section has been established to help patients increase their own personal knowledge in regards to their pain symptoms and conditions. Here we have provided you with the ability to digitally break down and pinpoint your area of discomfort, along with the steps included to beginning a diagnosis and treatment of the pain.
What is Platelets Rich Plasma (PRP)?
Platelets rich plasma therapy (PRP) is one of the newest, most cutting-edge treatments available. Based on the healing power of a patient’s own blood, platelets contain growth promoting qualities. When released they naturally promote the healing of tissue and bone cells at the injury site. PRP takes that process a step further by directly introducing an increased quantity of platelets to the site of pain and injury, thus providing a greater concentration of growth promoting factors to spur healing and tissue repair. This procedure has been used by many professional sports teams and leading medical centers.
Why PRP Work?
Human platelets are naturally extremely rich in connective tissue growth factors, injecting these growth factors into damaged ligaments and tendons stimulates a natural repair process. But in order to benefits from these natural healing proteins, the platelets must first be concentrated. In other work, PRP recreates and stimulates the body’s natural healing process.
How is PRP Treatment Done?
In the surgical center, blood is drawn from the patient and placed in a special centrifuge where the blood is spun down. The platelets are separated from the red blood cells and are concentrated. The red blood cells are discarded, and the resulting platelet concentrate is used for treatment. While the blood is spinning, the patient is either provided local anesthetic (injected) or conscious sedation (via IV). The entire treatment, from blood draw, to solution preparation, to injection, takes approximately 20 minutes.
How Often are injections Given?
Some patients respond very well to just one treatment. However, typically 2 treatments are necessary.
Recovery After PRP Treatment
After the initial treatment, exercise begins the next day and a follow up visit is scheduled the next week. Usually pain relief occurs within the first week and continues to improve over a period of months.
What Conditions Benefits PRP?
What Are the Long Term Affects of PRP?
PRP is not a band-aid or a “quick fix” but rather a long lasting and potentially permanent reparative process if the area is not overused or re-injured after the treatment series and especially if the patient commits to even a minimal home exercise program with emphasis on core strengthening. The soft tissue cables that connect the bones of the spine together are regenerated in a way, since they have reverted back to a functional healthy length and width that allows them maximum strength balanced with ideal range of motion. The healing process is gradual and progressive, initially subtle during the early phases but usually significant and dramatic by the completion of treatment. More endurances, less pain, and better function will continue to be noticed over time.
What is the role of PRP in the Spine?
Lemper Pain Centers is leading the country in PRP spine therapy. As one of few teams performing this procedure, we are able to offer PRP in the spine.
Spinal Nerve Inflammation Facet Joint Arthritis Disc Herniation or Tear Interspinous Ligament Sprain
Unexpected accidents and injuries can happen on a daily basis ranging in severity from mild to extreme pain and in some cases drastically altering the way we live. Diagnosing and treatment of pain injuries is very specific. At Lemper Pain Centers we take into account the patients lifestyle, work environment, and daily activities.
Chronic Obstructive Pulmonary Disease
Chronic Obstructive Pulmonary Disease (COPD) is an umbrella term that encompasses 2 main disorders— emphysema and chronic bronchitis–diseases that are characterized by obstruction to air flow in and out of the lungs. Emphysema and chronic bronchitis frequently coexist. Thus physicians prefer the term COPD. COPD is a slowly progressive disease of the airways that is characterized by a gradual loss of of lung function.
In Emphysema, the air sacs and small airways (bronchioles) are damaged and have lost their elasticity. When a person with emphysema breathes out, stale air becomes trapped inside the air sacs. This makes it harder for fresh air (oxygen) to come in and waste air (carbon dioxide) to go out. The blood vessels around the air sacs can be damaged too. This also prevents fresh air (oxygen) from reaching the bloodstream and waste air (carbon dioxide) from going out of the body. In almost all cases, COPD is caused by smoking. If you smoke, quit Smoking.
COPD – How it affects you
The symptoms of COPD can range from chronic cough and sputum (‘phlegm’) production to severe disabling shortness of breath. In some individuals, chronic cough and sputum production are the first signs that they are at risk for developing the airflow obstruction and shortness of breath characteristic of COPD. In others, shortness of breath may be the first indication of the disease. Individuals with COPD increasingly lose their ability to breathe. Acute infections or certain weather conditions may temporarily worsen symptoms (exacerbations), occasionally where hospitalization may be required.
The progression of the disease and the loss of lung function can be so gradual that, presently, many patients don’t realize they have COPD till late. Check if you are likely to have COPD. People with COPD may first notice breathlessness during activities such as climbing stairs and walking uphill. There is often wheezing and coughing that brings up mucus. Over time, the breathlessness worsens, sometimes to the point where dressing and bathing are also difficult. Oxygen levels in the blood may fall and carbon dioxide levels may rise, which can cause tiredness, poor concentration and heart strain. The strained heart may enlarge and lead to swelling of the ankles and legs called edema.
Some Statistics on COPD
The World Health Organization (WHO) estimates that COPD as a single cause of death shares 4th and 5th places with HIV/AIDS (after coronary heart disease, cerebrovascular disease and acute respiratory infection). In developed countries such as the US, COPD is the only major fatal disease the death rate of which is increasing – a disparity all the more striking amid the dramatic decline in deaths from heart disease and stroke. The WHO estimates that in 2000, 2.74 million people died of COPD worldwide. In 1990, a study by the World Bank and WHO ranked COPD 12th as a burden of disease; by 2020, it is estimated that COPD will be ranked 5th. According to the WHO, passive smoking carries serious risks, especially for children and those chronically exposed. The WHO estimates that passive smoking is associated with a 10 to 43 percent increase in risk of COPD in adults.
Platelets Rich Plasma for COPD
AURUM Healthcare PNA System is an innovative medical device for the preparation of Platelet Rich Plasma (PRP) and administering of PRP treatment to patients with respiratory diseases such as pneumonia, chronic obstructive pulmonary diseases (COPD) and for patients with shortness of breath and difficulty in breathing.
In the past, PRP has proven its success in orthopedics by healing musculoskeletal tissues through injections in the trunk and extremities which initiate reparative cell signaling. It is not until recently that PRP has begun to be experimented outside the traditional means of treatment. New experimental evidence suggests that PRP can be advantageous when it is injected into cardiac muscle or the spine but there is no reported evidence of PRP being used on the lungs or as part of a breathing treatment. Most research of PRP has been limited and has excluded internal organ systems because of the requirements for the intravenous needle system.
Platelet Rich Plasma is a concentrated form of growth factors and cytokines that are naturally present in blood clots. The concept is attractive because the patient’s own blood is used, limiting the potential for disease transmission when using PRP as a therapeutic modality. Effective use of PRP requires an understanding of exactly what it is. When an injury occurs, platelets release factors within the clot that stimulate the recruitment of mesenchymal cells to the site and promote their proliferation. These factors also reduce inflammation and stimulate angiogenesis.
Major components of PRP include Transforming Growth Factor-beta (TGF-ßs), Platelet-Derived Growth Factors (PDGF), Insulin-like Growth Factor (IGF), Vascular Endothelial Growth Factors (VEGF), and Fibroblast Growth Gactor-2 (FGF-2). TGF-ß1, IGF-1, and PDGF stimulate proliferation of mesenchymal cells; TGF-ß1 in particular stimulates extracellular matrix production, including collagen.
These factors are important for stabilizing tissue during the initial phases of tissue repair. VEGF and FGF-2 are important for stimulating new blood vessel formation to bring nutrients and progenitor cells to the site. Additional factors are needed for stabilization of the neovasculature. Thus, PRP is considered as an adjunctive therapy for specific applications.
PRP has been used as an additive for bone graft and bone graft substitutes. The factors present in PRP would augment the properties of bone graft, making it as effective as bone morphogenetic protein (BMP) and more cost-effective. Recent studies suggest that PRP is very effective in applications where enhanced angiogenesis and vasculogenesis are critical, such as in the treatment of traumatic injuries or large bone defects. This is particularly the case for tendon repair, where PRP has shown the greatest promise. Several recent studies in patients indicate that the use of PRP improves tendon healing.
A variety of methods are now commercially available for preparing PRP and a similar material termed “autologous growth factors”, which is PRP plus the white blood cell buffy coat obtained during PRP preparation. In addition, certain methods for combining PRP with other biologics or substitutes have also been commercialized in the orthopaedics arena.